nc525
·Code: NC525
nc525: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NextCure, Inc. (NXTC) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-Label, Safety, Tolerability, And Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Frequently asked questions
Who is developing nc525?
nc525 is being developed by NextCure, Inc..
How many clinical trials involve nc525?
BioSniper tracks 1 clinical trial involving nc525.
Get deeper analysis on nc525
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis